$OPRX Cashflow Statement | Understand Stock

$OPRX

$9.06 -$0.01 (0.11%) Close

$OPRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Noncash lease expense
Increase in bad debt reserve
Depreciation and amortization
Loss on disposal of business
Impairment charges
Bad debt expense
Stock-based compensation
Amortization of debt issuance costs
Change in:
Accounts receivable
Prepaid expenses and other assets
Accounts payable
Revenue share payable
Change in operating lease liabilities
Accrued expenses and other liabilities
Operating lease liabilities
Taxes receivable and payable
Deferred tax liabilities
Deferred loan fees
Deferred revenue
NET CASH PROVIDED BY OPERATING ACTIVITIES

INVESTING ACTIVITIES:
Purchases of property and equipment
Proceeds from sale of property and equipment
Cash paid for acquisitions, net of cash acquired
Proceeds from sale of business
Purchase of short-term investments
Acquisition of intangible assets, including intellectual property rights
Redemptions of short-term investments
Capitalized software development costs and other
Capitalized software development costs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

FINANCING ACTIVITIES:
Proceeds from public offering of common stock, net of offering costs
Proceeds from long-term debt, net of issuance costs
Repayment of long-term debt
Repurchase of common stock
Cash paid for employee withholding taxes related to the vesting of restricted stock units
Proceeds from exercise of stock options, net of cash paid for withholding taxes
Payment of contingent consideration
NET CASH USED IN FINANCING ACTIVITIES

NET DECREASE IN CASH AND CASH EQUIVALENTS
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD
CASH AND CASH EQUIVALENTS – END OF PERIOD
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
ROU assets obtained in exchange for lease obligations
Reduction of EvinceMed purchase price for amounts previously paid
Shares issued in connection with acquisition
Cash paid for income taxes

Comments